The National Institutes of Health last month awarded Northwestern University researcher Erik Sontheimer a two-year grant to help him develop siRNAs targeting genes involved in the inhibition of RNA interference.
According to the grant's abstract, such siRNAs could be used to boost the efficacy of a potential RNAi-based therapeutic.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
